Supplemental material
OncoImmunology
Volume 8, 2019 - Issue 11
Original Research
Dexamethasone differentially depletes tumour and peripheral blood lymphocytes and can impact the efficacy of chemotherapy/checkpoint blockade combination treatment
Wayne J. AstonNational Centre for Asbestos Related Diseases, The University of Western Australia, Nedlands, WA, Australia;Medical School, The University of Western Australia, Nedlands, WA, Australia
https://orcid.org/0000-0003-2736-419XView further author information
https://orcid.org/0000-0003-2736-419XView further author information, Danika E. HopeNational Centre for Asbestos Related Diseases, The University of Western Australia, Nedlands, WA, Australia;School of Biomedical Sciences, The University of Western Australia, Nedlands, WA, Australiahttps://orcid.org/0000-0001-5312-4355View further author information
https://orcid.org/0000-0001-5312-4355View further author information, Alistair M. CookNational Centre for Asbestos Related Diseases, The University of Western Australia, Nedlands, WA, Australia;Medical School, The University of Western Australia, Nedlands, WA, Australiahttps://orcid.org/0000-0001-5339-5374View further author information
https://orcid.org/0000-0001-5339-5374View further author information, Louis BoonBioceros, Utrecht, The Netherlandshttps://orcid.org/0000-0002-0937-9171View further author information
https://orcid.org/0000-0002-0937-9171View further author information, Ian DickNational Centre for Asbestos Related Diseases, The University of Western Australia, Nedlands, WA, Australia;School of Biomedical Sciences, The University of Western Australia, Nedlands, WA, Australiahttps://orcid.org/0000-0003-1902-9033View further author information
https://orcid.org/0000-0003-1902-9033View further author information, Anna K. NowakNational Centre for Asbestos Related Diseases, The University of Western Australia, Nedlands, WA, Australia;Medical School, The University of Western Australia, Nedlands, WA, Australia;Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australiahttps://orcid.org/0000-0002-9317-9526View further author information
https://orcid.org/0000-0002-9317-9526View further author information, Richard A. LakeNational Centre for Asbestos Related Diseases, The University of Western Australia, Nedlands, WA, Australia;School of Biomedical Sciences, The University of Western Australia, Nedlands, WA, Australiahttps://orcid.org/0000-0002-7765-602XView further author information
https://orcid.org/0000-0002-7765-602XView further author information & W. Joost LesterhuisNational Centre for Asbestos Related Diseases, The University of Western Australia, Nedlands, WA, Australia;School of Biomedical Sciences, The University of Western Australia, Nedlands, WA, AustraliaCorrespondence[email protected]
https://orcid.org/0000-0002-2718-276XView further author information
https://orcid.org/0000-0002-2718-276XView further author information show all